dje101

David Eschelman, MD, FSIR

Contact Dr. Eschelman

132 South 10th Street
Suite 766E, Main Building
Philadelphia, PA 19107

(215) 955-7304
(215) 923-6754 fax

Most Recent Peer-reviewed Publications

  1. Inferior Vena Cava Filter Placement and Retrieval Rates among Radiologists and Nonradiologists
  2. Do quantitative metrics derived from standard fluoroscopy phantoms used for quality control assess vendor-specific advancements in interventional fluoroscopy systems?
  3. A phantom study and a retrospective clinical analysis to investigate the impact of a new image processing technology on radiation dose and image quality during hepatic embolization
  4. Yttrium-90 microsphere brachytherapy for liver metastases from uveal melanoma clinical outcomes and the predictive value of fluorodeoxyglucose positron emission tomography
  5. Arterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma Cells
  6. Trends in use of percutaneous versus open surgical drainage of abdominal abscesses
  7. Uveal melanoma metastatic to the liver: Chemoembolization with 1,3-bis-(2-chloroethyl)-1-nitrosourea
  8. Double-blinded, randomized phase II study using embolization with or without granulocyte-macrophage colony-stimulating factor in uveal melanoma with hepatic metastases
  9. Early arterial stasis during resin-based yttrium-90 radioembolization: Incidence and preliminary outcomes
  10. Transhepatic therapies for metastatic uveal melanoma
  11. Single-center comparison of three chemoembolization regimens for hepatocellular carcinoma
  12. Combined hepatic arterial embolization and hepatic ablation for unresectable colorectal metastases to the liver
  13. Radiation emission from patients treated with selective hepatic radioembolization using yttrium-90 microspheres: Are contact restrictions necessary?
  14. Toxicities after radioembolization with yttrium-90 SIR-spheres: Incidence and contributing risk factors at a single center
  15. Moxifloxacin prophylaxis for chemoembolization or embolization in patients with previous biliary interventions: A pilot study
  16. Side-branch embolization before90Y radioembolization: Rate of recanalization and new collateral development
  17. The use of a covered stent in carotid blowout syndrome
  18. Radioembolization as salvage therapy for hepatic metastasis of uveal melanoma: A single-institution experience
  19. High-dose immunoembolization: Survival benefit in patients with hepatic metastases from uveal melanoma
  20. Immunoembolization of malignant liver tumors, including uveal melanoma, using granulocyte-macrophage colony-stimulating factor